Ranbaxy US

Ranbaxy US News

USFDA stops all Ranbaxy drugs, fourth plant banned

This is the fourth facility of the generic drug manufacturer to be charged by the US health regulator with such violations and the move stops all drug shipments from the company to the US.

Ranbaxy plans expansion in US

They make profits. We make drugs: Arun Sawhney

Advertising
Advertising